Crossmark

Effect of small-vessel disease on cognitive trajectory after atrial fibrillation-related ischaemic stroke or TIA

Crossref DOI link: https://doi.org/10.1007/s00415-019-09256-6

Published Online: 2019-03-07

Published Print: 2019-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Banerjee, Gargi https://orcid.org/0000-0003-0190-7782
Chan, Edgar

Ambler, Gareth

Wilson, Duncan

Cipolotti, Lisa

Shakeshaft, Clare

Cohen, Hannah

Yousry, Tarek

Lip, Gregory Y. H.

Muir, Keith W.

Brown, Martin M.

Jäger, Hans Rolf

Werring, David J.
Funding

Funding for this research was provided by:

British Heart Foundation (BHF TSA 2009/01)

Stroke Association (BHF TSA 2009/01)

Rosetrees Trust
License Information

Text and Data Mining valid from 2019-03-07
More Information

Article History

Received: 7 January 2019

Revised: 16 February 2019

Accepted: 19 February 2019

First Online: 7 March 2019

Compliance with ethical standards

:

: HC has received institutional research support from Bayer; honoraria for lectures and an Advisory Board from Bayer, diverted to a local charity; and travel/accommodation expenses for participation in scientific meetings covered by Bayer. GYHL acts as a consultant for Bayer/Janssen, BMS/Pfizer, Medtronic, Boehringer Ingelheim, Novartis, Verseon and Daiichi-Sankyo, and as a speaker for Bayer, BMS/Pfizer, Medtronic, Boehringer Ingelheim, and Daiichi-Sankyo; no fees are directly received personally. The remaining authors report no disclosures or conflicts of interest relevant to the manuscript.